MedicaidPrior AuthMedium impact
Byooviz® (ranibizumab-nuna) (Revised)
Humana·LA · Ophthalmology·Medicaid
Effective date
Jan 1, 2024
We identified it
Jun 24, 2026
Summary
Humana Medicaid Louisiana has updated prior authorization requirements for Byooviz (ranibizumab-nuna) intravitreal injections used to treat eye conditions. The drug requires prior auth and patients must have contraindications to bevacizumab or failed bevacizumab therapy before approval.
Action Required
Immediately: When prescribing Byooviz for wet AMD, macular edema following RVO, or myopic choroidal neovascularization, billing team must obtain prior authorization from Humana Medicaid Louisiana. Providers must document contraindications to bevacizumab OR prior bevacizumab failure with attestation that patient showed no positive clinical response. Visit www.humana.com/PAL for medical coding information and prior auth requirements.